Free Trial

Synaptics Incorporated (NASDAQ:SYNA) Holdings Cut by Aquatic Capital Management LLC

Synaptics logo with Computer and Technology background

Aquatic Capital Management LLC reduced its position in shares of Synaptics Incorporated (NASDAQ:SYNA - Free Report) by 33.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,921 shares of the software maker's stock after selling 5,979 shares during the period. Aquatic Capital Management LLC's holdings in Synaptics were worth $910,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Louisiana State Employees Retirement System raised its stake in shares of Synaptics by 1.8% in the 4th quarter. Louisiana State Employees Retirement System now owns 11,100 shares of the software maker's stock valued at $847,000 after acquiring an additional 200 shares during the period. State of Michigan Retirement System increased its holdings in Synaptics by 2.1% during the 4th quarter. State of Michigan Retirement System now owns 9,533 shares of the software maker's stock worth $728,000 after purchasing an additional 200 shares during the last quarter. Arizona State Retirement System raised its holdings in Synaptics by 1.8% in the fourth quarter. Arizona State Retirement System now owns 11,573 shares of the software maker's stock valued at $883,000 after acquiring an additional 200 shares in the last quarter. Bridge City Capital LLC lifted its position in shares of Synaptics by 0.9% during the fourth quarter. Bridge City Capital LLC now owns 22,511 shares of the software maker's stock worth $1,718,000 after purchasing an additional 201 shares during the last quarter. Finally, Inspire Advisors LLC grew its position in shares of Synaptics by 2.7% in the 4th quarter. Inspire Advisors LLC now owns 8,175 shares of the software maker's stock worth $624,000 after acquiring an additional 212 shares in the last quarter. Hedge funds and other institutional investors own 99.43% of the company's stock.

Synaptics Price Performance

NASDAQ SYNA traded down $0.29 on Tuesday, reaching $57.77. The company's stock had a trading volume of 80,125 shares, compared to its average volume of 466,754. The firm's 50 day moving average is $57.71 and its two-hundred day moving average is $70.16. The stock has a market cap of $2.26 billion, a PE ratio of 13.66 and a beta of 1.67. The company has a debt-to-equity ratio of 0.60, a quick ratio of 3.36 and a current ratio of 3.88. Synaptics Incorporated has a twelve month low of $41.80 and a twelve month high of $98.00.

Insider Buying and Selling at Synaptics

In other news, insider Ken Rizvi acquired 3,600 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The stock was purchased at an average price of $69.15 per share, with a total value of $248,940.00. Following the purchase, the insider now owns 27,630 shares of the company's stock, valued at approximately $1,910,614.50. This trade represents a 14.98 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have weighed in on SYNA. Needham & Company LLC reiterated a "buy" rating and set a $90.00 target price on shares of Synaptics in a research note on Tuesday, February 4th. Craig Hallum raised Synaptics from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, January 29th. Susquehanna boosted their price target on shares of Synaptics from $95.00 to $105.00 and gave the company a "positive" rating in a report on Wednesday, January 22nd. Rosenblatt Securities reaffirmed a "buy" rating and issued a $105.00 price objective on shares of Synaptics in a report on Thursday, February 27th. Finally, Mizuho decreased their target price on shares of Synaptics from $90.00 to $80.00 and set an "outperform" rating for the company in a research report on Monday, March 24th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $95.00.

View Our Latest Report on Synaptics

Synaptics Company Profile

(Free Report)

Synaptics Incorporated develops, markets, and sells semiconductor products worldwide. The company offers AudioSmart for voice and audio processing; ConnectSmart for high-speed video/audio/data connectivity; DisplayLink for transmitting compressed video frames across low bandwidth connections; VideoSmart that enables set-top boxes, over-the-top, streaming devices, soundbars, surveillance cameras, and smart displays; and ImagingSmart solutions.

Featured Stories

Institutional Ownership by Quarter for Synaptics (NASDAQ:SYNA)

Should You Invest $1,000 in Synaptics Right Now?

Before you consider Synaptics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synaptics wasn't on the list.

While Synaptics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines